PKMYT1AR and non-small cell lung carcinoma: Here, we demonstrated that PKMYT1AR was increased, whereas miR-485-5p was decreased, in cancerous tissues as well as peripheral blood serum isolated from NSCLC patients compared with reciprocal control groups, suggesting that PKMYT1AR and miR-485-5p functions as an oncogene, and a tumor suppressor, respectively, during NSCLC progression.